Skip to main content
Smart Investors Daily
ConvaTec Group Plc logo

NASDAQ · CNVVY

ConvaTec Group Plc

Healthcare · Medical - Instruments & Supplies

$13.03

Up+$0.43 (+3.41%)

Updated Aug 19, 2026, 5:57 AM

SID Score

5.8/10

Composite research score

Smart Money

46/100

Neutral

Market cap
6.28B
P/E ratio
28.99
Dividend yield
2.00%
52-week range
— – —
Volume
119
Avg. volume
24.37K

Price performance

CNVVY price history

1M range · 0 trading sessions · Daily adjusted prices

CNVVY does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest CNVVY news

The latest Smart Investors Daily articles mentioning CNVVY.

CNVVY research

Overview

Company profile and research snapshot.

Company profile

CONVATEC GRP PLC UNSP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$16.93
Implied upside
Analysts
21
CNVVY recent ratings
DateFirmRatingTarget
Jun 8, 2026JefferiesBuy
May 22, 2026JP Morgan CazenoveOverweight
May 18, 2026UBSBuy
May 18, 2026CitigroupNeutral
May 15, 2026JefferiesBuy
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Aug 4, 2026

ConvaTec Group H1 Earnings Call Highlights

ConvaTec Group (LON:CTEC) said it remained on track to meet its 2026 financial targets after reporting 5% organic revenue growth in the first half, excluding the impact of its InnovaMatrix skin-substitute product. The company said revenue growth was broad-based across its four chronic-care categori

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.